User profiles for Brian Clarke

Brian A. Clarke

Geomorphologist
Verified email at geomorphsolutions.com
Cited by 592

A critical assessment of docking programs and scoring functions

…, CW Andrews, AM Capelli, B Clarke… - Journal of medicinal …, 2006 - ACS Publications
Docking is a computational technique that samples conformations of small molecules in
protein binding sites; scoring functions are used to assess which of these conformations best …

Identification of ubiquitin ligases required for skeletal muscle atrophy

…, E Latres, S Baumhueter, VKM Lai, L Nunez, BA Clarke… - Science, 2001 - science.org
Skeletal muscle adapts to decreases in activity and load by undergoing atrophy. To identify
candidate molecular mediators of muscle atrophy, we performed transcript profiling. Although …

[PDF][PDF] The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle

BA Clarke, D Drujan, MS Willis, LO Murphy… - Cell metabolism, 2007 - cell.com
Skeletal muscle atrophy occurs as a side effect of treatment with synthetic glucocorticoids
such as dexamethasone (DEX) and is a hallmark of cachectic syndromes associated with …

Market competition, management accounting systems and business unit performance

L Mia, B Clarke - Management Accounting Research, 1999 - Elsevier
Increasing competition in the market, due to the application of modern manufacturing technology,
deregulation of economies, and privatization or corporatization of government owned …

Canadian Cardiovascular Society guidelines for evaluation and management of cardiovascular complications of cancer therapy

SA Virani, S Dent, C Brezden-Masley, B Clarke… - Canadian Journal of …, 2016 - Elsevier
Modern treatment strategies have led to improvements in cancer survival, however, these
gains might be offset by the potential negative effect of cancer therapy on cardiovascular health…

[HTML][HTML] The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

TN Stitt, D Drujan, BA Clarke, F Panaro, Y Timofeyva… - Molecular cell, 2004 - cell.com
Skeletal muscle size depends upon a dynamic balance between anabolic (or hypertrophic)
and catabolic (or atrophic) processes. Previously, no link between the molecular mediators …

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3) K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways

C Rommel, SC Bodine, BA Clarke, R Rossman… - Nature cell …, 2001 - nature.com
Skeletal muscle is composed of multinucleated fibres, formed after the differentiation and
fusion of myoblast precursors 1 . Skeletal muscle atrophy and hypertrophy refer to changes in …

Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt

C Rommel, BA Clarke, S Zimmermann, L Nunez… - Science, 1999 - science.org
Extracellular signals often result in simultaneous activation of both the Raf-MEK-ERK and
PI3K-Akt pathways (where ERK is extracellular-regulated kinase, MEK is mitogen-activated …

CCS/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction

…, S Zieroth, K Anderson, SA Bray, B Clarke… - Canadian Journal of …, 2021 - Elsevier
In this update of the Canadian Cardiovascular Society heart failure (HF) guidelines, we provide
comprehensive recommendations and practical tips for the pharmacologic management …

Crystal Structure of the IMP-1 Metallo β-Lactamase from Pseudomonas aeruginosa and Its Complex with a Mercaptocarboxylate Inhibitor:  Binding Determinants of a Potent …

…, P Rowling, S Pearson, CA Cheever, BP Clarke… - Biochemistry, 2000 - ACS Publications
Metallo β-lactamase enzymes confer antibiotic resistance to bacteria by catalyzing the hydrolysis
of β-lactam antibiotics. This relatively new form of resistance is spreading unchallenged …